Drug
Human Plasma Derived Fibrinogen Concentrate
Human Plasma Derived Fibrinogen Concentrate: highest development phase Phase 1/2, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Human Plasma-Derived Fibrinogen Concentrate NCT02281500 | Phase 1/2 | Congenital Afibrinogenemia |
Latest
No recent events.
Follow Human Plasma Derived Fibrinogen Concentrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.